Physicians and Industry: How should we behave?
Cardiosource: " Physicians and Industry: How should we behave?
Author: Alfred A. Bove, M.D., Ph.D, F.A.C.C.
Author Disclosure: Stock Options, Consulting Fees: Insight Telehealth.
Date: 9/21/2005
Much has been written in the public press over the past several months regarding conflicts of interest between physicians and the drug and device industries. This has been peppered with examples of physicians providing inside information regarding results of clinical trials to investment managers, sale of stock by physicians with inside information regarding a drug or device recall or clinical problem, and substantial withholding of important information about adverse effects of drugs or devices that ultimately resulted in severe losses for the companies. From the beginning of a medical career, industry is visible through gifts, conferences, and the ubiquitous "Drug Rep." (How many of us have a pen in our pocket with an imprinted product name?) We solicit funds for training of our fellows, and when properly managed, feel that this donation is a worthwhile educational endeavor as long as there is no content dictated by the granting company. We are often funded by pharmaceutical companies to conduct basic research, small and large clinical trials. Many investigators have built a career on research funding from drug or device companies."/.../
Author: Alfred A. Bove, M.D., Ph.D, F.A.C.C.
Author Disclosure: Stock Options, Consulting Fees: Insight Telehealth.
Date: 9/21/2005
Much has been written in the public press over the past several months regarding conflicts of interest between physicians and the drug and device industries. This has been peppered with examples of physicians providing inside information regarding results of clinical trials to investment managers, sale of stock by physicians with inside information regarding a drug or device recall or clinical problem, and substantial withholding of important information about adverse effects of drugs or devices that ultimately resulted in severe losses for the companies. From the beginning of a medical career, industry is visible through gifts, conferences, and the ubiquitous "Drug Rep." (How many of us have a pen in our pocket with an imprinted product name?) We solicit funds for training of our fellows, and when properly managed, feel that this donation is a worthwhile educational endeavor as long as there is no content dictated by the granting company. We are often funded by pharmaceutical companies to conduct basic research, small and large clinical trials. Many investigators have built a career on research funding from drug or device companies."/.../
posted by Aloyzio Achutti at 7:31 PM
0 Comments:
Post a Comment
<< Home